14-3-3 protein sigma isoform co-localizes with phosphorylated αD-synuclein in Lewy bodies and Lewy neurites in patients with Lewy body disease

被引:9
|
作者
Wakabayashi, Kaori [1 ]
Umahara, Takahiko [1 ,2 ]
Hirokawa, Katsuiku [3 ]
Hanyu, Haruo [2 ]
Uchihara, Toshiki [1 ]
机构
[1] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Setagaya Ku, 2-1-9 Kamikitazawa, Tokyo 1568506, Japan
[2] Tokyo Med Univ, Dept Geriatr Med, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan
[3] Nitobe Mem Nakano Gen Hosp, Dept Pathol, Tokyo, Japan
关键词
14-3-3; proteins; Sigma isoform; Lewy body; alpha-Synuclein; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; 14-3-3-PROTEINS; BRAINS; EXPRESSION; IMMUNOLOCALIZATION; TRANSLOCATION; SYSTEM; CANCER;
D O I
10.1016/j.neulet.2018.03.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha-Synuclein shares structural homology with 14-3-3 proteins. Seven 14-3-3 protein isoforms have been identified in mammals. Among them, the 14-3-3 sigma isoform was initially considered absent in the mammalian brain. However, we previously identified immunohistochemical association of 14-3-3 sigma with Pick bodies. Because 14-3-3 isoforms other than sigma isoform have been identified in Lewy bodies, we were prompted to look for this 14-3-3 sigma-like immunoreactivity (IR) in Lewy bodies in the brainstem, cerebral cortex, and Lewy neurites in seven patients with Lewy body disease. Unexpectedly, 14-3-3 sigma-like IR was consistently found in various types of Lewy pathologies in all cases examined. Double labeling studies confirmed its colocalization with alpha-synuclein. In general, 14-3-3 proteins can trap and hold some phosphorylated proteins in the cytoplasm and they can prevent or mediate apoptosis and survival of some cells. More precisely, the 14-3-3 sigma isoform is unique in its multiple cellular functions such as facilitating cell cycle arrest in the G2 phase, positively regulating p53, and suppressing tumor growth. Although the precise role of 14-3-3 sigma in the development of Lewy pathology remains elusive, its consistent association to Lewy pathology may expand our understanding of Lewy pathogenesis.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 22 条
  • [1] 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains
    Kawamoto, Y
    Akiguchi, I
    Nakamura, S
    Honjyo, Y
    Shibasaki, H
    Budka, H
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (03) : 245 - 253
  • [2] Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
    Su, Bo
    Liu, Haihua
    Wang, Xinglong
    Chen, Shu G.
    Siedlak, Sandra L.
    Kondo, Eisaku
    Choi, Raymond
    Takeda, Atsushi
    Castellani, Rudy J.
    Perry, George
    Smith, Mark A.
    Zhu, Xiongwei
    Lee, Hyoung-gon
    MOLECULAR NEURODEGENERATION, 2009, 4
  • [3] Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
    Irizarry, MC
    Growdon, W
    Gomez-Isla, T
    Newell, K
    George, JM
    Clayton, DF
    Hyman, BT
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (04) : 334 - 337
  • [4] Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
    Bo Su
    Haihua Liu
    Xinglong Wang
    Shu G Chen
    Sandra L Siedlak
    Eisaku Kondo
    Raymond Choi
    Atsushi Takeda
    Rudy J Castellani
    George Perry
    Mark A Smith
    Xiongwei Zhu
    Hyoung-gon Lee
    Molecular Neurodegeneration, 4
  • [5] 14-3-3 protein is a component of Lewy bodies in Parkinson's disease -: Mutation analysis and association studies of 14-3-3 eta
    Ubl, A
    Berg, D
    Holzmann, C
    Krüger, R
    Berger, K
    Arzberger, T
    Bornemann, A
    Riess, O
    MOLECULAR BRAIN RESEARCH, 2002, 108 (1-2): : 33 - 39
  • [6] Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
    McFerrin, Michael B.
    Chi, Xiaofei
    Cutter, Gary
    Yacoubian, Talene A.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (07): : 466 - 477
  • [7] Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies
    Arima, K
    Hirai, S
    Sunohara, N
    Aoto, K
    Izumiyama, Y
    Uéda, K
    Ikeda, K
    Kawai, M
    BRAIN RESEARCH, 1999, 843 (1-2) : 53 - 61
  • [8] Abnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease
    Dalfó, E
    Barrachina, M
    Rosa, JL
    Ambrosio, S
    Ferrer, I
    NEUROBIOLOGY OF DISEASE, 2004, 16 (01) : 92 - 97
  • [9] 14-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis
    Kawamoto, Y
    Akiguchi, I
    Nakamura, S
    Budka, H
    ACTA NEUROPATHOLOGICA, 2004, 108 (06) : 531 - 537
  • [10] Genetic analysis of α-synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies
    Tagliafierro, Lidia
    Glenn, Omolara-Chinue
    Zamora, Madison E.
    Beach, Thomas G.
    Woltjer, Randy L.
    Lutz, Michael W.
    Chiba-Falek, Ornit
    ALZHEIMERS & DEMENTIA, 2017, 13 (11) : 1237 - 1250